These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35727933)

  • 1. [A new paradigm for the development of neurodegenerative diseases on the example of Alzheimer's disease and Parkinson's disease.].
    Litvinenko IV; Lobzin VY
    Adv Gerontol; 2022; 35(2):263-273. PubMed ID: 35727933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metals, oxidative stress and neurodegenerative disorders.
    Jomova K; Vondrakova D; Lawson M; Valko M
    Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common and Trace Metals in Alzheimer's and Parkinson's Diseases.
    Doroszkiewicz J; Farhan JA; Mroczko J; Winkel I; Perkowski M; Mroczko B
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of zinc, copper, manganese and iron in neurodegenerative diseases.
    Mezzaroba L; Alfieri DF; Colado Simão AN; Vissoci Reiche EM
    Neurotoxicology; 2019 Sep; 74():230-241. PubMed ID: 31377220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurodegenerative diseases and therapeutic strategies using iron chelators.
    Ward RJ; Dexter DT; Crichton RR
    J Trace Elem Med Biol; 2015; 31():267-73. PubMed ID: 25716300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.
    Dhib-Jalbut S; Arnold DL; Cleveland DW; Fisher M; Friedlander RM; Mouradian MM; Przedborski S; Trapp BD; Wyss-Coray T; Yong VW
    J Neuroimmunol; 2006 Jul; 176(1-2):198-215. PubMed ID: 16983747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of mercury and arsenic in the etiology and pathogenesis of Parkinson's and Alzheimer's diseases].
    Salkov VN; Voronkov DN; Khudoerkov RM
    Arkh Patol; 2022; 84(5):59-64. PubMed ID: 36178224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics.
    Belaidi AA; Bush AI
    J Neurochem; 2016 Oct; 139 Suppl 1():179-197. PubMed ID: 26545340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease.
    Van Bulck M; Sierra-Magro A; Alarcon-Gil J; Perez-Castillo A; Morales-Garcia JA
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30743990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
    Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
    J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse and neurodegenerative diseases: focus on ferroptosis.
    Guo C; Chen L; Wang Y
    Arch Toxicol; 2023 Jun; 97(6):1519-1528. PubMed ID: 37100932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation in Lewy body dementia.
    Surendranathan A; Rowe JB; O'Brien JT
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1398-406. PubMed ID: 26493111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures.
    Myhre O; Utkilen H; Duale N; Brunborg G; Hofer T
    Oxid Med Cell Longev; 2013; 2013():726954. PubMed ID: 23710288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of microglia in the development of neurodegeneration.
    Saitgareeva AR; Bulygin KV; Gareev IF; Beylerli OA; Akhmadeeva LR
    Neurol Sci; 2020 Dec; 41(12):3609-3615. PubMed ID: 32458252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of the Inflammasome in Neurodegenerative Diseases.
    Piancone F; La Rosa F; Marventano I; Saresella M; Clerici M
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33670164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endotoxin hypothesis of neurodegeneration.
    Brown GC
    J Neuroinflammation; 2019 Sep; 16(1):180. PubMed ID: 31519175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A friend in need may not be a friend indeed: role of microglia in neurodegenerative diseases.
    Kaushik DK; Basu A
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):726-40. PubMed ID: 24070095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.